Waters Corporation [WAT] Stock Forecast

MILFORD, Mass. , Nov. 16, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra Ph.D.

Waters' (WAT) Q3 results benefit from a strong Pharmaceutical market, as well as a strong contribution from the Wyatt acquisition.

Waters Corporation (NYSE:WAT ) Q3 2023 Earnings Conference Call November 7, 2023 8:00 AM ET Company Participants Caspar Tudor – Head-Investor Relations Udit Batra – President and Chief Executive Officer Amol Chaubal – Senior Vice President and Chief Financial Officer Conference Call Participants Vijay Kumar – Evercore ISI Dan Brennan – TD Cowen Matt Sykes – Goldman Sachs Derik De Bruin – Bank of America Rachel Vatnsdal – JPMorgan Eve Burstein – Bernstein Research Operator Good morning. Welcome to the Waters Corporation Third Quarter 2023 Financial Results Conference Call.

Evaluate the expected performance of Waters (WAT) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Waters' (WAT) third-quarter 2023 results are likely to reflect strength in liquid chromatography instruments and mass spectrometers amid uncertainties in the global economy.

There is no easy way to select individual stocks. Measures of financial quality can highlight companies that are worth a closer look, but a decision to commit money must also take into consideration both recent developments and a look ahead.

Waters (WAT) partners with the University of San Agustin to provide the latter with technology equipment in its newly developed mass spectrometry imaging center in the Philippines.

Waters Corporation has pushed lower into H2 FY'23, in continuation of the longer-term downtrend. WAT's acquisition of Wyatt Technology was a large premium that to me signaled a lack of profitable investment runway. Despite exceptional returns on existing capital, the incremental returns don't match these numbers, clamping earnings and FCF growth.

Waters Corporation has seen a significant hit to its share price as momentum has left the life sciences tools space and as spending from the key biopharma end-market has corrected. Biopharma spending likely won't return to the torrid pace of the boom years, but ongoing investments into discovery tools, production equipment, and QA/QC equipment should drive healthy growth. The company's presence in industrial markets, such as food and water quality testing, provides a steady source of profitability and growth potential in areas like battery testing and sustainable polymers.

Waters Corporation (NYSE:WAT ) Bank of America Global Healthcare Conference 2023 Call September 13, 2023 8:20 AM ET Company Participants Udit Batra - President and Chief Executive Officer Conference Call Participants Derik De Bruin - Bank of America Merrill Lynch Derik De Bruin Good afternoon, and welcome to Bank of America's Global Healthcare Conference Community Live from London. I'm Derik De Bruin, the Senior U.S. Life Sciences and Diagnostics Tools analyst, and it is my pleasure to welcome our next company, which is Waters Corp. Today with me, we have Dr. Udit Batra, President and CEO of Waters.

Waters Corporation is a US stock , located in Milford of Ma and trading under the symbol WAT

2 stock analysts have 2 predictions with a medium analyst target price of $340. The lowest prediction is $315 and the highest is $365

Waters Corporation stock price is $275.95 today.

Yes, Waters Corporation is a publicly traded company.